CD5 and acute lymphoblastic leukemia: After completing the functional validation of CD5 CAR-T cells in vitro, we established a mouse tumor model of T cell acute lymphoblastic leukemia (T-ALL) by tail intravenous injection of CCRF-CEM-ffLuc cells to verify the in vivo efficacy of CD5 CAR-T cells.